List of Tables
Table 1. Global RET Inhibitors Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global RET Inhibitors Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global RET Inhibitors Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global RET Inhibitors Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global RET Inhibitors Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global RET Inhibitors Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
Table 7. Global RET Inhibitors Sales by Region (2020-2025) & (K Units)
Table 8. Global RET Inhibitors Sales by Region (2026-2031) & (K Units)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global RET Inhibitors Sales by Manufacturers (2020-2025) & (K Units)
Table 11. Global RET Inhibitors Sales Share by Manufacturers (2020-2025)
Table 12. Global RET Inhibitors Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global RET Inhibitors Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global RET Inhibitors by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in RET Inhibitors as of 2024)
Table 16. Global RET Inhibitors Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global RET Inhibitors Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
Table 18. Key Manufacturers RET Inhibitors Manufacturing Base and Headquarters
Table 19. Global RET Inhibitors Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global RET Inhibitors Sales by Type (2020-2025) & (K Units)
Table 23. Global RET Inhibitors Sales by Type (2026-2031) & (K Units)
Table 24. Global RET Inhibitors Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global RET Inhibitors Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global RET Inhibitors ASP by Type (2020-2031) & (US$/Unit)
Table 27. Technical Specifications by Key Product Type
Table 28. Global RET Inhibitors Sales by Application (2020-2025) & (K Units)
Table 29. Global RET Inhibitors Sales by Application (2026-2031) & (K Units)
Table 30. RET Inhibitors High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global RET Inhibitors Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global RET Inhibitors Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global RET Inhibitors ASP by Application (2020-2031) & (US$/Unit)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America RET Inhibitors Growth Accelerators and Market Barriers
Table 37. North America RET Inhibitors Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America RET Inhibitors Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 39. Europe RET Inhibitors Growth Accelerators and Market Barriers
Table 40. Europe RET Inhibitors Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe RET Inhibitors Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific RET Inhibitors Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific RET Inhibitors Sales (K Units) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific RET Inhibitors Growth Accelerators and Market Barriers
Table 45. Southeast Asia RET Inhibitors Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America RET Inhibitors Investment Opportunities and Key Challenges
Table 47. Central and South America RET Inhibitors Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa RET Inhibitors Investment Opportunities and Key Challenges
Table 49. Middle East and Africa RET Inhibitors Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Eli Lilly Corporation Information
Table 51. Eli Lilly Description and Major Businesses
Table 52. Eli Lilly Product Models, Descriptions and Specifications
Table 53. Eli Lilly Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 54. Eli Lilly Sales Value Proportion by Product in 2024
Table 55. Eli Lilly Sales Value Proportion by Application in 2024
Table 56. Eli Lilly Sales Value Proportion by Geographic Area in 2024
Table 57. Eli Lilly RET Inhibitors SWOT Analysis
Table 58. Eli Lilly Recent Developments
Table 59. Blueprint Medicines Corporation Information
Table 60. Blueprint Medicines Description and Major Businesses
Table 61. Blueprint Medicines Product Models, Descriptions and Specifications
Table 62. Blueprint Medicines Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 63. Blueprint Medicines Sales Value Proportion by Product in 2024
Table 64. Blueprint Medicines Sales Value Proportion by Application in 2024
Table 65. Blueprint Medicines Sales Value Proportion by Geographic Area in 2024
Table 66. Blueprint Medicines RET Inhibitors SWOT Analysis
Table 67. Blueprint Medicines Recent Developments
Table 68. Genentech Inc. Corporation Information
Table 69. Genentech Inc. Description and Major Businesses
Table 70. Genentech Inc. Product Models, Descriptions and Specifications
Table 71. Genentech Inc. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 72. Genentech Inc. Sales Value Proportion by Product in 2024
Table 73. Genentech Inc. Sales Value Proportion by Application in 2024
Table 74. Genentech Inc. Sales Value Proportion by Geographic Area in 2024
Table 75. Genentech Inc. RET Inhibitors SWOT Analysis
Table 76. Genentech Inc. Recent Developments
Table 77. Innovnent Biologics Corporation Information
Table 78. Innovnent Biologics Description and Major Businesses
Table 79. Innovnent Biologics Product Models, Descriptions and Specifications
Table 80. Innovnent Biologics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 81. Innovnent Biologics Sales Value Proportion by Product in 2024
Table 82. Innovnent Biologics Sales Value Proportion by Application in 2024
Table 83. Innovnent Biologics Sales Value Proportion by Geographic Area in 2024
Table 84. Innovnent Biologics RET Inhibitors SWOT Analysis
Table 85. Innovnent Biologics Recent Developments
Table 86. Key Raw Materials Distribution
Table 87. Raw Materials Key Suppliers
Table 88. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 89. Milestones in Production Technology Evolution
Table 90. Distributors List
Table 91. Market Trends and Market Evolution
Table 92. Market Drivers and Opportunities
Table 93. Market Challenges, Risks, and Restraints
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. RET Inhibitors Product Picture
Figure 2. Global RET Inhibitors Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Pralsetinib Product Picture
Figure 4. Selpercatinib Product Picture
Figure 5. Global RET Inhibitors Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Non-Small Cell Lung Cancer (NSCLC)
Figure 7. Thyroid Carcinoma
Figure 8. Others
Figure 9. RET Inhibitors Report Years Considered
Figure 10. Global RET Inhibitors Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global RET Inhibitors Revenue (2020-2031) & (US$ Million)
Figure 12. Global RET Inhibitors Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global RET Inhibitors Revenue Market Share by Region (2020-2031)
Figure 14. Global RET Inhibitors Sales (2020-2031) & (K Units)
Figure 15. Global RET Inhibitors Sales (CAGR) by Region (2020-2031) (K Units)
Figure 16. Global RET Inhibitors Sales Market Share by Region (2020-2031)
Figure 17. Top 5 and Top 10 Manufacturers RET Inhibitors Sales Volume Market Share in 2024
Figure 18. Global RET Inhibitors Revenue Market Share Ranking (2024)
Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 20. Pralsetinib Revenue Market Share by Manufacturer in 2024
Figure 21. Selpercatinib Revenue Market Share by Manufacturer in 2024
Figure 22. Global RET Inhibitors Sales Market Share by Type (2020-2031)
Figure 23. Global RET Inhibitors Revenue Market Share by Type (2020-2031)
Figure 24. Global RET Inhibitors Sales Market Share by Application (2020-2031)
Figure 25. Global RET Inhibitors Revenue Market Share by Application (2020-2031)
Figure 26. North America RET Inhibitors Sales YoY (2020-2031) & (K Units)
Figure 27. North America RET Inhibitors Revenue YoY (2020-2031) & (US$ Million)
Figure 28. North America Top 5 Manufacturers RET Inhibitors Sales Revenue (US$ Million) in 2024
Figure 29. North America RET Inhibitors Sales Volume (K Units) by Type (2020- 2031)
Figure 30. North America RET Inhibitors Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 31. North America RET Inhibitors Sales Volume (K Units) by Application (2020-2031)
Figure 32. North America RET Inhibitors Sales Revenue (US$ Million) by Application (2020-2031)
Figure 33. US RET Inhibitors Revenue (2020-2031) & (US$ Million)
Figure 34. Canada RET Inhibitors Revenue (2020-2031) & (US$ Million)
Figure 35. Mexico RET Inhibitors Revenue (2020-2031) & (US$ Million)
Figure 36. Europe RET Inhibitors Sales YoY (2020-2031) & (K Units)
Figure 37. Europe RET Inhibitors Revenue YoY (2020-2031) & (US$ Million)
Figure 38. Europe Top 5 Manufacturers RET Inhibitors Sales Revenue (US$ Million) in 2024
Figure 39. Europe RET Inhibitors Sales Volume (K Units) by Type (2020-2031)
Figure 40. Europe RET Inhibitors Sales Revenue (US$ Million) by Type (2020-2031)
Figure 41. Europe RET Inhibitors Sales Volume (K Units) by Application (2020-2031)
Figure 42. Europe RET Inhibitors Sales Revenue (US$ Million) by Application (2020-2031)
Figure 43. Germany RET Inhibitors Revenue (2020-2031) & (US$ Million)
Figure 44. France RET Inhibitors Revenue (2020-2031) & (US$ Million)
Figure 45. U.K. RET Inhibitors Revenue (2020-2031) & (US$ Million)
Figure 46. Italy RET Inhibitors Revenue (2020-2031) & (US$ Million)
Figure 47. Russia RET Inhibitors Revenue (2020-2031) & (US$ Million)
Figure 48. Asia-Pacific RET Inhibitors Sales YoY (2020-2031) & (K Units)
Figure 49. Asia-Pacific RET Inhibitors Revenue YoY (2020-2031) & (US$ Million)
Figure 50. Asia-Pacific Top 8 Manufacturers RET Inhibitors Sales Revenue (US$ Million) in 2024
Figure 51. Asia-Pacific RET Inhibitors Sales Volume (K Units) by Type (2020- 2031)
Figure 52. Asia-Pacific RET Inhibitors Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 53. Asia-Pacific RET Inhibitors Sales Volume (K Units) by Application (2020-2031)
Figure 54. Asia-Pacific RET Inhibitors Sales Revenue (US$ Million) by Application (2020-2031)
Figure 55. Indonesia RET Inhibitors Revenue (2020-2031) & (US$ Million)
Figure 56. Japan RET Inhibitors Revenue (2020-2031) & (US$ Million)
Figure 57. South Korea RET Inhibitors Revenue (2020-2031) & (US$ Million)
Figure 58. China Taiwan RET Inhibitors Revenue (2020-2031) & (US$ Million)
Figure 59. India RET Inhibitors Revenue (2020-2031) & (US$ Million)
Figure 60. Central and South America RET Inhibitors Sales YoY (2020-2031) & (K Units)
Figure 61. Central and South America RET Inhibitors Revenue YoY (2020-2031) & (US$ Million)
Figure 62. Central and South America Top 5 Manufacturers RET Inhibitors Sales Revenue (US$ Million) in 2024
Figure 63. Central and South America RET Inhibitors Sales Volume (K Units) by Type (2021-2031)
Figure 64. Central and South America RET Inhibitors Sales Revenue (US$ Million) by Type (2020-2031)
Figure 65. Central and South America RET Inhibitors Sales Volume (K Units) by Application (2020-2031)
Figure 66. Central and South America RET Inhibitors Sales Revenue (US$ Million) by Application (2020-2031)
Figure 67. Brazil RET Inhibitors Revenue (2020-2025) & (US$ Million)
Figure 68. Argentina RET Inhibitors Revenue (2020-2025) & (US$ Million)
Figure 69. Middle East, and Africa RET Inhibitors Sales YoY (2020-2031) & (K Units)
Figure 70. Middle East and Africa RET Inhibitors Revenue YoY (2020-2031) & (US$ Million)
Figure 71. Middle East and Africa Top 5 Manufacturers RET Inhibitors Sales Revenue (US$ Million) in 2024
Figure 72. Middle East and Africa RET Inhibitors Sales Volume (K Units) by Type (2021-2031)
Figure 73. South America RET Inhibitors Sales Revenue (US$ Million) by Type (2020-2031)
Figure 74. Middle East and Africa RET Inhibitors Sales Volume (K Units) by Application (2020-2031)
Figure 75. Middle East and Africa RET Inhibitors Sales Revenue (US$ Million) by Application (2020-2031)
Figure 76. GCC Countries RET Inhibitors Revenue (2020-2025) & (US$ Million)
Figure 77. Turkey RET Inhibitors Revenue (2020-2025) & (US$ Million)
Figure 78. Egypt RET Inhibitors Revenue (2020-2025) & (US$ Million)
Figure 79. South Africa RET Inhibitors Revenue (2020-2025) & (US$ Million)
Figure 80. RET Inhibitors Industry Chain Mapping
Figure 81. Regional RET Inhibitors Manufacturing Base Distribution (%)
Figure 82. Global RET Inhibitors Production Market Share by Region (2020-2031)
Figure 83. RET Inhibitors Production Process
Figure 84. Regional RET Inhibitors Production Cost Structure
Figure 85. Channels of Distribution (Direct Vs Distribution)
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed
